ALL-106: Outcomes of Blinatumomab, the Initial Phase of Chemotherapy in Children With B-Cell Acute Lymphoblastic Leukemia: A Single-Center Study
Sapura IbragimovaScientific and Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, UzbekistanAlbina KlevleevaScientific and Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, UzbekistanNargiza BabakhanovaScientific and Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, UzbekistanF RizayevaScientific and Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, UzbekistanIndira ErimbetovaScientific and Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, UzbekistanK NigmatovScientific and Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, UzbekistanN AripovaScientific and Practical Medical Center for Pediatric Oncology, Hematology and Immunology, Tashkent, Uzbekistan
ABI
Annotatsiya
Annotatsiya mavjud emas.
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos0 ta foydalanilgan manba